{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:39:55Z","timestamp":1777887595108,"version":"3.51.4"},"reference-count":7,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2026.1856197","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:18:20Z","timestamp":1777609100000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial: Advancing chemotherapy against protozoan parasites: development and repurposing of therapeutic compounds"],"prefix":"10.3389","volume":"17","author":[{"given":"Rafael M.","family":"Mariante","sequence":"first","affiliation":[{"name":"Laboratory of Structural Biology, Instituto Oswaldo Cruz, Fiocruz","place":["Rio de Janeiro, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda F.","family":"Evangelista","sequence":"additional","affiliation":[{"name":"Universidade Federal da Integra\u00e7\u00e3o Latino-Americana","place":["Foz do Igua\u00e7u, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor V. P.","family":"Midlej","sequence":"additional","affiliation":[{"name":"Laboratory of Structural Biology, Instituto Oswaldo Cruz, Fiocruz","place":["Rio de Janeiro, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana Q.","family":"Reim\u00e3o","sequence":"additional","affiliation":[{"name":"Laboratory of Preclinical Assays and Research of Alternative Sources of Innovative Therapy for Toxoplasmosis and Other Sicknesses (PARASITTOS), Faculdade de Medicina de Jundia\u00ed","place":["Jundia\u00ed, Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.3390\/ijms20225748","article-title":"An overview of drug resistance in protozoal diseases","volume":"20","author":"Capela","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s40257-022-00726-8","article-title":"Cutaneous leishmaniasis: a 2022 updated narrative review into diagnosis and management developments","volume":"23","author":"de Vries","year":"2022","journal-title":"Am. J. Clin. Dermatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e00057-17","DOI":"10.1128\/CMR.00057-17","article-title":"Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice","volume":"31","author":"Dunay","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"101084","DOI":"10.1016\/j.jpha.2024.101084","article-title":"Exploration of innovative drug repurposing strategies for combating human protozoan diseases: advances, challenges, and opportunities","volume":"15","author":"Hu","year":"2025","journal-title":"J. Pharm. Anal."},{"key":"B5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01787-7","article-title":"Chagas disease","volume":"403","author":"Sousa","year":"2024","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/bs.pmbts.2024.05.001","article-title":"Drug repurposing for parasitic protozoan diseases","volume":"207","author":"Vijayasurya","year":"2024","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0012735","DOI":"10.1371\/journal.pntd.0012735","article-title":"Progress in antileishmanial drugs: mechanisms, challenges, and prospects","volume":"19","author":"Zhang","year":"2025","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1856197\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:18:20Z","timestamp":1777609100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1856197\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":7,"alternative-id":["10.3389\/fphar.2026.1856197"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1856197","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"article-number":"1856197"}}